BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12718084)

  • 1. [Refractory idiopathic thrombocytopenic purpura].
    Iki S; Urabe A
    Nihon Rinsho; 2003 Apr; 61(4):609-14. PubMed ID: 12718084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura.
    George JN; Kojouri K; Perdue JJ; Vesely SK
    Semin Hematol; 2000 Jul; 37(3):290-8. PubMed ID: 10942223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A; Catlett JP
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
    Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
    Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outline of treatment--strategy of initial therapy].
    Ohtake H; Miyazaki K; Higashihara M
    Nihon Rinsho; 2003 Apr; 61(4):587-92. PubMed ID: 12718080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
    Kojouri K; George JN
    Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura.
    McMillan R
    Blood Rev; 2002 Mar; 16(1):51-5. PubMed ID: 11913996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults.
    George JN
    Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial management of adults with idiopathic (immune) thrombocytopenic purpura.
    George JN
    Blood Rev; 2002 Mar; 16(1):37-8. PubMed ID: 11913992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z; Yang R
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic thrombocytopenic purpura].
    Nomura S
    Nihon Rinsho; 2003 Apr; 61(4):552-7. PubMed ID: 12718074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial splenic embolization as a preoperative treatment for refractory idiopathic thrombocytopenic purpura].
    Sadamoto Y; Abe Y; Kato K; Nishimura J
    Rinsho Ketsueki; 1998 Dec; 39(12):1194-6. PubMed ID: 10028854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.